A transplant pharmacist reported via a BMS sales representative that 2 patients experienced adverse events while 
receiving belatacept therapy.  This report represents patient 2 of 2. 
A male patient tested postive for JC BK virus but did not manifest any symptoms. The reporter stated that the 
patient's "counts were low." No additional information was reported.
Supplemental ad hoc query response was received on 09-Apr-2014.  The transplant pharmacist indicated that due 
to HIPA regulations, she was unable to provide any further information on this patient.
Print Time: 24-MAY-2016 07:56 AM If a field is blank, there is no data for that field Page 23 of 570
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information